Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL - CONFIDENTIAL
COG Protocol AHOD1331 entitled, “A Randomized Phase III Study of Brentuximab vedotin (IND#117117) for Newly Diagnosed Classical Hodgkin Lymphoma (cHL) in Children and Adolescents”
SUBCONTRACTE shall carry out the clinical trial research sub-study, “Cost Effectiveness Analysis (CEA) of Brentuximab Vedotin in Newly Diagnosed High-Risk Classical Hodgkin lymphoma (cHL) in Children and Adolescents,” set forth in the research protocol COG Protocol AHOD1331 entitled, “A Randomized Phase III Study of Brentuximab vedotin (IND#117117) for Newly Diagnosed Classical Hodgkin Lymphoma (cHL) in Children and Adolescents”
Status | Finished |
---|---|
Effective start/end date | 3/8/17 → 5/3/21 |
Funding
- Childrens Hospital of Philadelphia: $2.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.